NewAmsterdam Pharma (NAMS) Other Gross PP&E Adjustments (2022 - 2025)
Historic Other Gross PP&E Adjustments for NewAmsterdam Pharma (NAMS) over the last 4 years, with Q3 2025 value amounting to -$2.3 million.
- NewAmsterdam Pharma's Other Gross PP&E Adjustments rose 2299.8% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.3 million, marking a year-over-year increase of 2299.8%. This contributed to the annual value of -$3.2 million for FY2024, which is 5296.61% down from last year.
- NewAmsterdam Pharma's Other Gross PP&E Adjustments amounted to -$2.3 million in Q3 2025, which was up 2299.8% from -$3.0 million recorded in Q2 2025.
- NewAmsterdam Pharma's Other Gross PP&E Adjustments' 5-year high stood at -$1.7 million during Q1 2024, with a 5-year trough of -$3.6 million in Q1 2025.
- Over the past 4 years, NewAmsterdam Pharma's median Other Gross PP&E Adjustments value was -$3.0 million (recorded in 2025), while the average stood at -$2.7 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first skyrocketed by 3152.8% in 2023, then plummeted by 11167.54% in 2025.
- Quarter analysis of 4 years shows NewAmsterdam Pharma's Other Gross PP&E Adjustments stood at -$3.1 million in 2022, then skyrocketed by 31.53% to -$2.1 million in 2023, then crashed by 52.97% to -$3.2 million in 2024, then increased by 28.38% to -$2.3 million in 2025.
- Its last three reported values are -$2.3 million in Q3 2025, -$3.0 million for Q2 2025, and -$3.6 million during Q1 2025.